150 related articles for article (PubMed ID: 34950770)
1. A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma.
Yang Y; Hua W; Zeng M; Yu L; Zhang B; Wen L
Open Med (Wars); 2022; 17(1):22-33. PubMed ID: 34950770
[TBL] [Abstract][Full Text] [Related]
2. Linc01278 inhibits the development of papillary thyroid carcinoma by regulating miR-376c-3p/DNM3 axis.
Lin S; Tan L; Luo D; Peng X; Zhu Y; Li H
Cancer Manag Res; 2019; 11():8557-8569. PubMed ID: 31572010
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
[TBL] [Abstract][Full Text] [Related]
4. CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p.
Zheng M; Xu L; Wei C; Guan W
Hormones (Athens); 2023 Jun; 22(2):281-293. PubMed ID: 36826778
[TBL] [Abstract][Full Text] [Related]
5. IncRNA XIST Stimulates Papillary Thyroid Cancer Development through the miR-330-3p/PDE5A Axis.
Cai T; He Y; Peng B
Crit Rev Eukaryot Gene Expr; 2023; 33(3):13-26. PubMed ID: 37017666
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
7. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells.
Liu Z; Hu K; Wang X; Zhang Y; Wang W; Wu Y
Open Med (Wars); 2022; 17(1):266-279. PubMed ID: 35274046
[TBL] [Abstract][Full Text] [Related]
8. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.
Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ
Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ZFAS1 promotes progression of papillary thyroid carcinoma by sponging miR-590-3p and upregulating HMGA2 expression.
Tong H; Zhuang X; Cai J; Ding Y; Si Y; Zhang H; Shen M
Onco Targets Ther; 2019; 12():7501-7512. PubMed ID: 31571903
[TBL] [Abstract][Full Text] [Related]
10. MiR-376c-3p targets heparin-binding EGF-like growth factor (HBEGF) to inhibit proliferation and invasion in medullary thyroid carcinoma cells.
Bai N; Hou D; Mao C; Cheng L; Li N; Mao X
Arch Med Sci; 2020; 16(4):878-887. PubMed ID: 32542091
[TBL] [Abstract][Full Text] [Related]
11. hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G
Luo Q; Guo F; Fu Q; Sui G
Mol Ther Nucleic Acids; 2021 Jun; 24():591-609. PubMed ID: 33898108
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
13. MiR-3121-3p promotes tumor invasion and metastasis by suppressing Rap1GAP in papillary thyroid cancer
Xu M; Zhou J; Zhang Q; Le K; Xi Z; Yi P; Zhao X; Tan J; Huang T
Ann Transl Med; 2020 Oct; 8(19):1229. PubMed ID: 33178761
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY
Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929
[TBL] [Abstract][Full Text] [Related]
15. Circ_0059354 aggravates the progression of papillary thyroid carcinoma by elevating ARFGEF1 through sponging miR-766-3p.
Li Z; Xu J; Guan H; Lai J; Yang X; Ma J
J Endocrinol Invest; 2022 Apr; 45(4):825-836. PubMed ID: 34854069
[TBL] [Abstract][Full Text] [Related]
16. MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1.
Wang C; Wang Y; Fu Z; Huang W; Yu Z; Wang J; Zheng K; Zhang S; Li S; Chen J
Front Oncol; 2022; 12():837581. PubMed ID: 35530352
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
[TBL] [Abstract][Full Text] [Related]
18. Linc00475 promotes the progression of glioma by regulating the miR-141-3p/YAP1 axis.
Yu M; Yi B; Zhou W; Gong W; Li G; Yu S
J Cell Mol Med; 2021 Jan; 25(1):463-472. PubMed ID: 33336871
[TBL] [Abstract][Full Text] [Related]
19. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.
Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
